التفاصيل البيبلوغرافية
| العنوان: |
Portal 5-hydroxytryptophan infusion enhances glucose disposal in conscious dogs. |
| المؤلفون: |
Moore, Mary Courtney, Kimura, Kazuhiro, Shibata, Haruki, Honjoh, Tsutomu, Saito, Masayuki, Everett, Carrie A., Smith, Marta S., Cherrington, Alan D. |
| المصدر: |
American Journal of Physiology: Endocrinology & Metabolism; Aug2005, Vol. 289, pE225-E231, 7p, 5 Charts, 4 Graphs |
| مصطلحات موضوعية: |
SEROTONIN, GLUCOSE, INFUSION therapy, GLUCAGON, HYPERGLYCEMIA, DOGS |
| مستخلص: |
Intraportal serotonin infusion enhances net hepatic glucose uptake (NHGU) during glucose infusion but blunts nonhepatic glucose uptake and can cause gastrointestinal discomfort and diarrhea at high doses. Whether the serotonin precursor 5-hydroxytryptophan (5-HTP) could enhance NHGU without gastrointestinal side effects during glucose infusion was examined in conscious 42-h-fasted dogs, using arteriovenous difference and tracer ([3-³H]glucose) techniques. Experiments consisted of equilibration (-120 to -30 min), basal (-30 to 0 min), and experimental (EXP; 0–270 min) periods. During EXP, somatostatin, four-fold basal intraportal insulin, basal intraportal glucagon, and peripheral glucose (to double the hepatic glucose load) were infused. In one group of dogs (HTP, n = 6), saline was infused intraportally from 0 to 90 min (P1), and 5-HTP was infused intraportally at 10, 20, and 40 μg·kg-1·min-1 from 90 to 150 (P2), 150 to 210 (P3), and 210 to 270 (P4) min, respectively. In the other group (SAL, n = 7), saline was infused intraportally from 0 to 270 min. NHGU in SAL was 14.8 ± 1.9, 18.5 ± 2.3, 16.3 ± 1.4, and 19.7 ± 1.6 μmol·kg-1·min-1 in P1–P4, whereas NHGU in 5-HTP averaged 16.4 ± 2.6, 18.5 ± 1.4, 20.8 ± 2.0, and 27.6 ± 2.6 μmol·kg-1·min-1 (P < 0.05 vs. SAL). Nonhepatic glucose uptake (μmol·kg-1·min-1) in SAL was 30.2 ± 4.3, 36.8 ± 5.8, 44.3 ± 5.8, and 54.6 ± 11.8 during P1–P4, respectively, whereas in HTP the corresponding values were 26.3 ± 6.8, 44.9 ± 10.1, 47.5 ± 11.7, and 51.4 ± 13.2 (not significant between groups). Intraportal 5-HTP enhances NHGU without significantly altering nonhepatic glucose uptake or causing gastrointestinal side effects, raising the possibility that a related agent might have a role in reducing postprandial hyperglycemia. [ABSTRACT FROM AUTHOR] |
|
Copyright of American Journal of Physiology: Endocrinology & Metabolism is the property of American Physiological Society and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) |
| قاعدة البيانات: |
Complementary Index |
Full Text Finder